[StP-05] Students and Junior Residents Poster Session 05「Neuroinfection, Headache, etc.」

[StP-05-4] How are CGRPmAbs used? Insights from a survey of the Japanese Headache Society members

Keiko Ihara^1,2, Tsubasa Takizawa^1,9, Narumi Watanabe¹, Ryo Takemura³, Nobuyuki Takahashi¹, Naoki Miyazaki³, Mamoru Shibata^4,9, Keisuke Suzuki^5,9, Noboru Imai^6,9, Norihiro Suzuki^7,9, Koichi Hirata^5,9, Takao Takeshima^8,9, Jin Nakahara¹ (1.Department of Neurology, Keio University School of Medicine, Japan, 2.Japanese Red Cross Ashikaga Hospital, Japan, 3.Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Japan, 4.Department of Neurology, Tokyo Dental College Ichikawa General Hospital, Japan, 5.Department of Neurology, Dokkyo Medical University, Japan, 6.Department of Neurology and Headache Center, Japanese Red Cross Shizuoka Hospital, Japan, 7.Department of Neurology, Shonan Keiiku Hospital, Japan, 8.Headache Center, Department of Neurology, Tominaga Hospital, Japan, 9.Task force for the use of anti-CGRP monoclonal antibodies, The Japanese Headache Society, Japan)